Zydus Lifesciences shares surged 7% to an intraday high of Rs 947.95 on the BSE on Thursday after receiving final approval ...

The uptick in Zydus Life share price came after the company announced that it has received final approval from the USFDA to ...

Dasatinib is the generic version of Sprycel® tablets, a medication widely used for treating Ph+, chronic myeloid leukemia ...

IT services company TCS has collaborated with Vantage Towers, Europe’s second-largest telecom tower operator, to introduce a ...

Zydus Lifesciences Ltd is quoting at Rs 906.2, up 2.11% on the day as on 12:49 IST on the NSE. The stock is down 7.22% in last one year as compared to a 0.19% fall in NIFTY and a 6.32% fall in the ...

The National Pharmaceutical Pricing Authority (NPPA) has notified the retail price of 53 new drugs based on applications submitted by individual companies, after finalising the same in the latest ...

AM(IST)on Thursday in an upbeat market. Gland Pharma Ltd.(up 3.66 per cent), Zydus Lifesciences Ltd.(up 3.17 per cent), ...

Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multiple strengths. The ...

The 30-share BSE Sensex was up 59.19 points at 73789.42 ...

On March 6, several key stocks are in focus. TCS has partnered with Vantage Towers to launch a digital service platform aimed at enhancing property owner experiences in telecom tower leasing. LIC ...

Prior to joining Eris, Ranganathan was Commercial Director, Women’s Health, Metabolics, and International Business at Abbott ...